Product code SBP— Microbiology

Xpert HCV; GeneXpert Xpress System

Classification name
Simple Point-Of-Care Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Test
Device class
Class 2
Regulation
21 CFR 866.3171
Advisory panel
Microbiology
Total cleared
1
First cleared
Most recent

FDA classification definition

“A simple point-of-care nucleic acid-based hepatitis C virus (HCV) ribonucleic acid (RNA) test is an in vitro diagnostic device that is intended for prescription use for the detection of HCV RNA in clinical specimens as an aid in the diagnosis of HCV infection or as an aid in the management of HCV-infected patients, including individuals without antibodies to HCV. This device is simple to use and does not involve sample manipulation, transportation of the sample to another functional area (e.g., a central laboratory or other specialized area), or measurement of reagents or analytes that could be affected by conditions such as sample turbidity or cell lysis. The test is not intended for use as a donor screening test for the presence of HCV RNA in blood, blood products, or tissue donors.”

— U.S. Food and Drug Administration, device classification record for product code SBP under 21 CFR 866.3171, via openFDA

Market context for product code SBP

FDA has cleared 1 device under product code SBP, all in 2024, filed by 1 applicant company. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Top applicants under product code SBP

Recent clearances under product code SBP

Data sourced from openFDA. This site is unofficial and independent of the FDA.